Pipeline | Indication | Discovery | Lead Optimization |
Pre-clinical | Phase1 | Phase2 | Phase3 | NDA | ||||||
FM101 | Non-alcoholic steatohepatitis | |||||||||||||
Glaucoma | ||||||||||||||
Diabetic nephropathy | ||||||||||||||
Primary biliary cholangitis | ||||||||||||||
FM203 | Viral disease (CHIKV, COVID, ZIKA) | |||||||||||||
FM301 | Metastatic and resistant pancreatic cancer | |||||||||||||
FM401 | Solid tumor | |||||||||||||
FM503 | Autoimmune disease | |||||||||||||
Hematologic cancer | FM701 | Non small cell lung carcinoma |
Pipeline | Indication | Graph |
FM101 | Non-alcoholic steatohepatitis | Phase2 |
Glaucoma | Phase2 |
|
Diabetic nephropathy | Phase1 |
|
Primary biliary cholangitis | Phase1 |
|
FM203 | Viral disease (CHIKV, COVID, ZIKA) | Pre-Clinical |
FM301 | Metastatic and resistant pancreatic cancer | Pre-Clinical |
FM401 | Solid tumor | Pre-Clinical |
FM503 | Autoimmune disease | Pre-Clinical |
Hematologic cancer | Pre-Clinical |
|
FM701 | Non small cell lung carcinoma | Pre-Clinical |
Pipeline | Indication | Graph |
FM101 | Non-alcoholic steatohepatitis | Phase2 |
Glaucoma | Phase2 |
|
Diabetic nephropathy | Phase1 |
|
Primary biliary cholangitis | Phase1 |
|
FM203 | Viral disease (CHIKV, COVID, ZIKA) | Pre-Clinical |
FM301 | Metastatic and resistant pancreatic cancer | Pre-Clinical |
FM401 | Solid tumor | Pre-Clinical |
FM503 | Autoimmune disease | Pre-Clinical |
Hematologic cancer | Pre-Clinical |
|
FM701 | Non small cell lung carcinoma | Pre-Clinical |